Search

UAE

NeOnc Technologies Reports Updated Clinical Results

Results of Clinical Trials Provide Evidence Supporting Significant Radiographic Response and Potential Long-Term Survival in Recurrent Grade III/IV IDH1-Mutant Astrocytoma Treated with Intranasal NEO100 CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program

CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing novel brain-penetrant therapeutics for patients with malignant brain tumors and central nervous system (CNS) disorders, today announced that

مجموعة أسياد تستعرض حلولها اللوجستية المتكاملة لسلاسل إمداد الطاقة خلال مؤتمر أديبك 2025

من البنية الأساسية للموانئ العميقة إلى أسطول متنوّع من الناقلات والسفن ودعم حلول الوقود النظيف، تقدّم مجموعة أسياد نموذجًا متكاملًا خلال معرض ومؤتمر أديبك 2025 Asyad at ADIPEC 2025 أبو ظبي, Nov. 04, 2025 (GLOBE NEWSWIRE) — تشارك مجموعة أسياد،

BTCS to Participate in Upcoming November Conferences

WAYNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) — BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that management will be participating in the following November 2025 investor conferences.

Aqua Labs Champions UAE Vision 2030

With $20 Million Global Startup Program And Summit Leadership in Dubai DUBAI, United Arab Emirates, Oct. 30, 2025 (GLOBE NEWSWIRE) — Aqua Labs, the emerging UAE-based Web3 investment group, has reinforced its commitment to the nation’s Economic Vision 2030 through